The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Cann Regulatory News (OCTP)

Share Price Information for Oxford Cann (OCTP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.345
Bid: 0.33
Ask: 0.36
Change: -0.005 (-1.43%)
Spread: 0.03 (9.091%)
Open: 0.35
High: 0.35
Low: 0.345
Prev. Close: 0.35
OCTP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding in Company

25 Jan 2023 12:09

RNS Number : 8616N
Oxford Cannabinoid Tech.Holdings
25 January 2023
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

Oxford Cannabinoid Technologies Holdings PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

X

An event changing the breakdown of voting rights

Other (please specify) iii:

3. Details of person subject to the notification obligation iv

Name

GHS Capital Limited

City and country of registered office (if applicable)

London, UK

4. Full name of shareholder(s) (if different from 3.) v

Name

Gavin Sathianathan and Lilijan Sulejmanovic (Gavin Sathianathan's wife)

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached vi:

24/01/2023

6. Date on which issuer notified (DD/MM/YYYY):

25/01/2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

0.25%

24,547,190

Position of previous notification (if

applicable)

4.39%

0.25%

4.64%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

GB00BMVMRB86

22,146,151

SUBTOTAL 8. A

22,146,151

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

Options

17/5/2031

17 May 2022 - 17 May 2031

800,347

0.083%

Options

17/5/2031

17 May 2023 - 17 May 2031

800,346

0.083%

Options

17/5/2031

17 May 2024 - 17 May 2031

800,346

0.083%

SUBTOTAL 8. B 1

2,401,039

0.25%

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

X

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

GHS Capital Limited

0.25

 

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information xvi

GHS Capital Limited, is a company wholly owned by Gavin Sathianathan and Lilijan Sulejmanovic (Gavin Sathianathan's wife)

The share options detailed in tables 7, 8B1 and 9 are held directly by Gavin Sathianathan and have an exexercise price of £0.065.

 

Place of completion

London UK

Date of completion

25 / 01 / 2023

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLBDGDBIGDDGXU
Date   Source Headline
11th Apr 202411:26 amRNSAppointment of Phase I Clinical Trial CRO
3rd Apr 20248:00 amRNSOCT Company Update with Doceo
26th Mar 202410:56 amRNSOxford Cannabinoid Technologies video with Doceo
18th Mar 20247:00 amRNSAppointment of Hybridan as Adviser
29th Feb 20247:02 amRNSDirectorate Appointment
29th Feb 20247:01 amRNSDirectorate Changes
29th Feb 20247:00 amRNSTotal Voting Rights
28th Feb 20245:35 pmRNSTR-1: NOTIFICATION OF MAJOR HOLDINGS
28th Feb 20245:34 pmRNSTR-1: NOTIFICATION OF MAJOR HOLDINGS
28th Feb 20245:34 pmRNSTR-1: NOTIFICATION OF MAJOR HOLDINGS
26th Feb 20241:07 pmRNSDirectors’ Dealings
19th Feb 20241:52 pmRNSResult of General Meeting
16th Feb 20247:00 amRNSCompletion of Capital Reorganisation
15th Feb 20247:00 amRNSSubscription
14th Feb 202412:53 pmRNSCapital Reorganisation
9th Feb 20247:00 amRNSEdison issues update on OCTP
2nd Feb 20243:17 pmRNSNotice of General Meeting & Posting of Circular
2nd Feb 20243:13 pmRNSConvertible Loan Note Agreements
30th Jan 20247:04 amRNSFundraising and Proposed Capital Reorganisation
30th Jan 20247:02 amRNSR&D Tax Credit
30th Jan 20247:00 amRNSHalf-year Report
23rd Jan 20247:00 amRNSNotice of Results
10th Jan 20247:00 amRNSPatent Applications
14th Nov 20237:00 amRNSDirectorate Appointment
24th Oct 20237:00 amRNSTR-1: Notification of major holdings
20th Oct 20237:01 amRNSTR-1: Notification of major holdings
20th Oct 20237:00 amRNSDirector Dealing
10th Oct 20237:00 amRNSPhase I Clinical Trial Results
29th Sep 20237:00 amRNSResult of AGM
25th Sep 20237:00 amRNSFinal Dose Administered
5th Sep 20234:18 pmRNSNotice of AGM
31st Aug 20237:00 amRNS2023 Final Results
22nd Aug 20237:00 amRNSNotice of Results
27th Jul 20237:00 amRNSFirst Dose Administered & Pain Specialist Adviser
17th Jul 20231:16 pmRNSDirector/PDMR Share Purchases
17th Jul 20237:00 amRNSExpansion into oncology
12th Jul 20237:00 amRNSInvestor Presentation and Q&A – Programmes update
15th Jun 20239:50 amRNSOCTP update from Doceo
8th Jun 20237:00 amRNSAppointment of Chief Medical Officer
17th May 20237:00 amRNSMHRA & REC 2 Approval for Phase 1 Clinical Trial
12th Apr 20237:00 amRNSDirectorate Change, Renewal of Licence & Update
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
13th Mar 20234:35 pmRNSPrice Monitoring Extension
7th Mar 202311:05 amRNSSecond Price Monitoring Extn
7th Mar 202311:00 amRNSPrice Monitoring Extension
6th Mar 202311:05 amRNSSecond Price Monitoring Extn
6th Mar 202311:00 amRNSPrice Monitoring Extension
25th Jan 202312:09 pmRNSHolding in Company
23rd Jan 20237:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.